<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H340533BD9AD145F2A06CD042D987D907" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 HR 1026 IH: Lessening Addiction By Enhancing Labeling Opioids Act of 2021</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2021-02-11</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">117th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 1026</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20210211">February 11, 2021</action-date><action-desc><sponsor name-id="S001211">Mr. Stanton</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HJU00">the Judiciary</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Controlled Substances Act to require dispensers of certain opioids and opiates to affix on the container or package thereof a clear, concise warning that the opioid or opiate can cause dependence, addiction, and overdose, and for other purposes.</official-title></form><legis-body id="H0BD5F63AA2434113AE1D0CA1FB0BB3D0" style="OLC"><section id="H85C881E4906543E1AC631D65DA81182C" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Lessening Addiction By Enhancing Labeling Opioids Act of 2021</short-title></quote> or the <quote><short-title>LABEL Opioids Act</short-title></quote>.</text></section><section id="H5E80E68BD41842E59B70AEEAD0FB43B3"><enum>2.</enum><header>Lessening addiction by enhancing labeling of opioids</header><subsection id="HDEDB491D65D44797958489F302C9FF86"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Section 305(c) of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/825">21 U.S.C. 825(c)</external-xref>) is amended by striking <quote>which shall provide that the label</quote> and all that follows through the period and inserting the following: </text><quoted-block style="OLC" id="H53D14B0AD07C4A8A82D411AC8EE1F10C" display-inline="yes-display-inline"><text>which shall provide that— </text><paragraph id="HA50A94D412994F7D962EEEEAF8C07C7A"><enum>(1)</enum><text display-inline="yes-display-inline">the label of a drug listed in schedule II, III, or IV shall, when dispensed to or for a patient, contain a clear, concise warning that it is a crime to transfer the drug to any person other than the patient; and</text></paragraph><paragraph id="H9DEF1764DC104C94A40331243EFB6157"><enum>(2)</enum><text>the label of any container or package containing an opioid or opiate listed in schedule II, III, IV, or V (other than a drug that is approved or authorized by the Food and Drug Administration for the treatment of addiction or an opioid use disorder) shall, when dispensed to or for a patient, contain a clear, concise warning that the opioids or opiates dispensed can cause dependence, addiction, and overdose.</text></paragraph><after-quoted-block>;</after-quoted-block></quoted-block></subsection><subsection id="H219F019B86B44AF9986991256C036468"><enum>(b)</enum><header>Prohibited act</header><text>Section 402(a)(3) of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/842">21 U.S.C. 842(a)(3)</external-xref>) is amended after <quote>distribute</quote> by inserting <quote>or dispense</quote>. </text></subsection><subsection id="H52167F5F08AA4FC6944F15B0E61F2919"><enum>(c)</enum><header>Regulations</header><paragraph commented="no" display-inline="no-display-inline" id="HDFC0DE4DD9FD40BE806D12CE8523D9DF"><enum>(1)</enum><header display-inline="yes-display-inline">Regulations</header><text display-inline="yes-display-inline">Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services shall prescribe final regulations to implement the amendments made by subsections (a) and (b), which regulations shall be effective beginning on the date that is 2 years after the date of enactment of this Act.</text></paragraph><paragraph id="H966E0BCEB1694FE5A45DBA94965FACC4"><enum>(2)</enum><header>Interim rules</header><text>The Secretary of Health and Human Services may issue the regulations required under paragraph (1) by interim rule to the extent necessary to comply with the timing requirement in paragraph (1).</text></paragraph></subsection><subsection id="HD0CEDED5ACE740268C7DFEC978BC3FC9"><enum>(d)</enum><header>Applicability</header><text>The amendment made by subsection (b) applies beginning on the date that is 2 years after the date of enactment of this Act.</text></subsection></section></legis-body></bill> 

